Histone deacetylase inhibitors for cardiovascular conditions and healthy longevity
Summary: Histone deacetylase inhibitors (HDACi) regulate gene expression via epigenetic mechanisms. Accumulating evidence suggests that HDACi exert antiproliferative, antioxidant, antineoplastic, and proapoptotic effects through epigenetic mechanisms. Furthermore, HDACi also exert antithrombotic and...
Main Authors: | João Pedro Ferreira, MD, Bertram Pitt, ProfMD, Faiez Zannad, ProfMD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | The Lancet. Healthy Longevity |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666756821000611 |
Similar Items
-
Age-related disparities in diabetes risk attributable to modifiable risk factor profiles in Chinese adults: a nationwide, population-based, cohort study
by: Tiange Wang, ProfPhD, et al.
Published: (2021-10-01) -
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
by: Monica Phimmachanh, et al.
Published: (2020-10-01) -
Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial
by: Pierre-Yves Benhamou, ProfMD, et al.
Published: (2019-05-01) -
Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020-08-01) -
Histone deacetylase inhibitors : mode of inhibition and histone deacetylase phosphorylation
by: Sekhavat, Anoushe
Published: (2013)